Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
5(63%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_3
1
13%
Ph phase_2
3
38%
Ph phase_1
4
50%

Phase Distribution

4

Early Stage

3

Mid Stage

1

Late Stage

Phase Distribution8 total trials
Phase 1Safety & dosage
4(50.0%)
Phase 2Efficacy & side effects
3(37.5%)
Phase 3Large-scale testing
1(12.5%)

Highest Phase Reached

Phase 3

Trial Status & Enrollment

Completion Rate

100.0%

3 of 3 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

5

trials recruiting

Total Trials

8

all time

Status Distribution
Active(5)
Completed(3)

Detailed Status

Completed3
Recruiting3
Active, not recruiting2

Development Timeline

Analytics

Development Status

Total Trials
8
Active
5
Success Rate
100.0%
Most Advanced
Phase 3

Trials by Phase

Phase 14 (50.0%)
Phase 23 (37.5%)
Phase 31 (12.5%)

Trials by Status

completed338%
recruiting338%
active_not_recruiting225%

Recent Activity

5 active trials
Showing 5 of 8
completedphase_1

A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

NCT07130097
recruitingphase_2

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

NCT04606446
recruitingphase_3

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

NCT06760637
active_not_recruitingphase_1

A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

NCT06206837
recruitingphase_1

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

NCT07160738
View all 8 trials

Clinical Trials (8)

Showing 8 of 8 trials
NCT07130097Phase 1

A Study to Compare Two Tablet Formulations of Study Medicine Atirmociclib in Healthy Participants

Completed
NCT04606446Phase 2

Study of PF-07248144 in Advanced or Metastatic Solid Tumors

Recruiting
NCT06760637Phase 3

Study of PF-07220060 With Letrozole in Adults With HR-positive HER2-negative Breast Cancer Who Have Not Received Anticancer Treatment for Advanced/Metastatic Disease

Recruiting
NCT06206837Phase 1

A Study to Learn About Vepdegestrant When Given With PF-07220060 to People With Advanced or Metastatic Breast Cancer.

Active Not Recruiting
NCT07160738Phase 1

A Study to Learn About How the Study Medicines Called Itraconazole and Probenecid Change How the Body Processes PF-07220060

Recruiting
NCT06897683Phase 1

A Study to Learn if the Study Medicine Called Carbamazepine Changes How the Body Processes PF-07220060

Completed
NCT06465368Phase 2

A Study to Learn About the Study Medicine PF-07220060 Together With Letrozole Compared to Letrozole Alone in Women Post Menopause

Completed
NCT04557449Phase 2

Study to Test the Safety and Tolerability of PF-07220060 in Participants With Advance Solid Tumors

Active Not Recruiting

All 8 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
8